Dashboard
Manage Tickers

MGXMetagenomi, Inc.

Nasdaq metagenomi.co


$ 2.74 $ -0.01 (-0.36 %)    

Tuesday, 17-Sep-2024 15:16:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.73 $ -3.24 (-0.68 %)
DIA $ 416.66 $ -1.33 (-0.32 %)
SPY $ 561.95 $ -3.18 (-0.56 %)
TLT $ 100.93 $ -0.46 (-0.45 %)
GLD $ 237.48 $ -0.50 (-0.21 %)
$ 2.74
$ 2.76
$ 2.73 x 100
$ 2.75 x 100
$ 2.68 - $ 2.85
$ 2.63 - $ 12.74
141,433
na
102.56M
$ 3.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-27-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

peeling-back-the-layers-exploring-metagenomi-through-analyst-insights
Peeling Back The Layers: Exploring Metagen...
09/06/2024 12:00:32

Core News & Articles
HC Wainwright & Co. Reiterates Buy on Meta...
09/06/2024 10:19:10

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Metagenomi (NASDAQ:MGX) with a Buy and maintains $7 price target.

Core News & Articles
Chardan Capital Maintains Buy on Metagenom...
09/05/2024 19:24:04

Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:MGX) with a Buy and maintains $15 price target.

Core News & Articles
Metagenomi Announces Durable Twelve-Month ...
09/03/2024 20:15:08

unveiling-4-analyst-insights-on-metagenomi
Unveiling 4 Analyst Insights On Metagenomi
08/21/2024 13:00:13

Core News & Articles
HC Wainwright & Co. Maintains Buy on Metag...
08/21/2024 12:36:38

HC Wainwright & Co. analyst Mitchell Kapoor maintains Metagenomi (NASDAQ:MGX) with a Buy and lowers the price target fro...

cogent-communications-to-rally-around-12-here-are-10-top-analyst-forecasts-for-monday
Cogent Communications To Rally Around 12%?...
08/19/2024 12:53:06

Core News & Articles
Chardan Capital Maintains Buy on Metagenom...
08/19/2024 12:35:05

Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:MGX) with a Buy and lowers the price target from $17 to...

Core News & Articles
BMO Capital Maintains Outperform on Metage...
08/15/2024 14:16:41

BMO Capital analyst Kostas Biliouris maintains Metagenomi (NASDAQ:MGX) with a Outperform and lowers the price target from $2...

Core News & Articles
Metagenomi Q2 EPS $(0.29) Beats $(0.65) Es...
08/14/2024 12:17:14

Metagenomi (NASDAQ:MGX) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.65) by ...

Core News & Articles
HC Wainwright & Co. Reiterates Buy on Meta...
07/15/2024 10:29:14

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Metagenomi (NASDAQ:MGX) with a Buy and maintains $10 price target.

Core News & Articles
HC Wainwright & Co. Reiterates Buy on Meta...
05/15/2024 15:09:24

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Metagenomi (NASDAQ:MGX) with a Buy and maintains $10 price target.

Core News & Articles
Metagenomi Q1 2024 Adj EPS $(1.19) Misses ...
05/14/2024 20:39:47

Metagenomi (NASDAQ:MGX) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.78) b...

Core News & Articles
HC Wainwright & Co. Initiates Coverage On ...
05/07/2024 10:10:21

HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Metagenomi (NASDAQ:MGX) with a Buy rating and announce...

moderna-reports-smaller-than-expected-q1-loss-prepares-for-rsv-vaccine-and-spikevax-2024-2025-formula-stock-soars
Moderna Reports Smaller Than Expected Q1 L...
05/02/2024 17:12:43

Moderna reports Q1 loss, beating sales estimates amidst declining COVID-19 vaccine demand. Cost-saving measures drive optimism ...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 16:31:17

Core News & Articles
JP Morgan Downgrades Metagenomi to Neutral...
05/02/2024 12:32:16

JP Morgan analyst Brian Cheng downgrades Metagenomi (NASDAQ:MGX) from Overweight to Neutral and lowers the price target from...

Core News & Articles
Metagenomi To Regain Full Development Righ...
05/01/2024 20:51:38

Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/19/2024 20:31:47

Core News & Articles
Chardan Capital Maintains Buy on Metagenom...
03/28/2024 12:23:29

Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:MGX) with a Buy and maintains $21 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION